US2022257667A1PendingUtilityA1

Compositions comprising bacterial strains

82
Assignee: 4D PHARMA PLCPriority: Mar 4, 2016Filed: Dec 2, 2021Published: Aug 18, 2022
Est. expiryMar 4, 2036(~9.6 yrs left)· nominal 20-yr term from priority
Inventors:Annick Bernalier-DonadilleLaureen CrouzetChloe Habouzit
A23C 9/1203A23C 9/152A23C 19/09A61K 35/741A61P 1/04A61P 1/00A23C 21/02A61P 29/00A61P 1/14A23V 2002/00A23G 9/363A23C 9/005A23L 33/135A61K 2035/11A61K 47/12A61K 35/74A61K 9/48A61K 47/38A61K 9/00A61K 47/02A61K 47/10A61K 2035/115A61K 9/0053A61K 9/19A61K 47/26A61K 47/36A61K 9/4891A61K 47/42A23V 2200/3204A61K 39/0208
82
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides compositions comprising one or more bacterial strains for treating or preventing visceral hypersensitivity.

Claims

exact text as granted — not AI-modified
1 . A composition comprising a bacterial strain of the genus  Blautia , for use in a method of treating or preventing visceral hypersensitivity. 
     
     
         2 - 31 . (canceled)

Join the waitlist — get patent alerts

Track US2022257667A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.